A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PEG-IFN

Search Conditions:
Search Keyword : PEG-IFN
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PEG-IFN
Appearance Frequency: 1302 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
pegylated interferon
(1021 times)
Gastroenterology
(439 times)
HCV (477 times)
SVR (409 times)
RBV (390 times)
2002 Present treatment expectations and risks of chronic hepatitis C.
peginterferon
(169 times)
Gastroenterology
(92 times)
HCV (77 times)
SVR (73 times)
RBV (71 times)
2002 Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.
peginterferon alfa-2a
(45 times)
Gastroenterology
(27 times)
RBV (16 times)
CHB (12 times)
HCV (12 times)
2004 Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial.
pegylated IFN
(45 times)
Gastroenterology
(16 times)
IFN (32 times)
HCV (19 times)
SVR (17 times)
2001 Hepatitis C: therapeutic perspectives.
peg interferon
(4 times)
Gastroenterology
(2 times)
HCV (2 times)
RBV (2 times)
CKD-EPI (1 time)
2011 Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patients.
polyethylene glycol-conjugated interferon
(4 times)
Gastroenterology
(1 time)
HCV (2 times)
Hsp90 (1 time)
PAGE (1 time)
2003 Treatment of chronic hepatitis C in nonresponders to previous therapy.
pegylated IFN-alpha
(3 times)
Gastroenterology
(3 times)
CHB (1 time)
GWAS (1 time)
HBV (1 time)
2010 lambda-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C.
polyethylene glycol-interferon
(2 times)
Antineoplastic Agents
(1 time)
CHC (1 time)
CLL (1 time)
HCV (1 time)
2012 [Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-alpha-2b].
dual-therapy-pegylated interferon
(1 time)
Microbiology
(1 time)
DAAs (1 time)
IFN (1 time)
RBV (1 time)
2018 Real-world challenges for hepatitis C virus medications: a critical overview.
10  kD-pegylated-interferon-alpha-2-b/ribavirin
(1 time)
Gastroenterology
(1 time)
--- 2006 From trials to a real hospital setting: effectiveness of pegylated interferon-alpha-2b/ribavirin combination therapy for naive chronic hepatitis C patients.
11  PEG-interferon conjugate
(1 time)
Biochemistry
(1 time)
PSar (1 time)
2018 Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation.
12  Pegilated-IFN
(1 time)
IFN (1 time)
MC (1 time)
RIBA (1 time)
2018 Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.
13  pegylated interferon-containing
(1 time)
Medicine
(1 time)
LDV/SOF (1 time)
SVR12 (1 time)
2017 Effectiveness and safety of ledipasvir/sofosbuvirribavirin in the treatment of HCV infection: The real-world HARVEST study.
14  polyethylene glycol interferon-alpha-2b
(1 time)
Allergy and Immunology
(1 time)
IL-2 (1 time)
2007 Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.
15  polyethylene glycol-conjugated IFN
(1 time)
Biomedical Research
(1 time)
IFN (1 time)
IM (1 time)
sscDNA (1 time)
2013 Optimization of a high-throughput whole blood expression profiling methodology and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjects.
16  telaprevir-peginterferon
(1 time)
Microbiology
(1 time)
aa (1 time)
HCV (1 time)
2014 Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection.
17  telaprevir-pegylated interferon
(1 time)
Microbiology
(1 time)
aa (1 time)
HCV-1b (1 time)
SVR (1 time)
2013 Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1.